Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Doc: Merck Fudged Minutes of Meeting

Vytorin probe challeges firm's account of delay in trial results

By Rob Quinn,  Newser Staff

Posted Apr 12, 2008 9:33 AM CDT

(Newser) – Merck's "minutes" of a meeting of heart doctors discussing cholesterol drug Vytorin were created a month after the meeting and distorted the viewpoints of the experts, one panel member changes. The drug company submitted the document to congressional investigators probing its two-year delay in releasing a report saying the drug didn't work any better than a much cheaper generic one, Bloomberg reports.

The minutes say the panel unanimously chose to change the study's objective, a decision the company made, and then withdrew, when experts called it unethical. But the doctor says the panel—who had been assured no minutes were being taken—merely discussed the pros and cons of such a move and didn't make any formal recommendations.

Chairman of the board of the German pharmaceutical and chemical company Merck, Karl-Ludwig Kley, speaks during the annual shareholders meeting in Frankfurt, central Germany, Friday, March 28, 2008.
Chairman of the board of the German pharmaceutical and chemical company Merck, Karl-Ludwig Kley, speaks during the annual shareholders meeting in Frankfurt, central Germany, Friday, March 28, 2008.   (AP Photo/Bernd Kammerer)
The cholesterol-lowering drug Vytorin, is shown in this undated photo provided by Schering-Plough Corp. Merck & Co.
The cholesterol-lowering drug Vytorin, is shown in this undated photo provided by Schering-Plough Corp. Merck & Co.   (AP Photo)
An employee walks past a stained-glass window, bearing Merck & Co.'s name, as he walks to the elevator at the company's headquarters in a Whitehouse Station, N.J. file photo.
An employee walks past a stained-glass window, bearing Merck & Co.'s name, as he walks to the elevator at the company's headquarters in a Whitehouse Station, N.J. file photo.   (AP Photo/Daniel Hulshizer, File)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

More Newser Stories

Firms Hid Bad News on Heart Drugs 2 Years: Doc

Scientists Still Question Popular Drugs Zetia, Vytorin

2 Top Cholesterol Drugs, Vytorin and Zetia, Don't Work

Congress to Probe 'Misleading' Drug Ads

Disgraced Doctors Land at Big Pharma


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne